Insights on augmenter of liver regeneration cloning and function

World Journal of Gastroenterology

Volumn 12, Issue 31, 2006, Pages 4951-4958

  Gatzidou, Elisavet ^a   Kouraklis, Gregory ^b   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Augmenter of liver regeneration; Hepatic stimulator substance; Liver regeneration; Molecular biology

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; HEPATOPOIETIN; RECOMBINANT HEPATOPOIETIN; RECOMBINANT PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; THIOL OXIDASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; DNA DETERMINATION; DNA SEQUENCE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC CODE; HUMAN; LIVER CELL; LIVER DISEASE; LIVER REGENERATION; MOLECULAR CLONING; NONHUMAN; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; YEAST;

EID: 33748288398     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i31.4951     Document Type: Review

References (73)

1. LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975; 248: 273-284
2. LaBrecque DR. Hepatic stimulator substance. Discovery, characteristics and mechanism of action. Dig Dis Sci 1991; 36: 669-673
3. Margeli AP, Skaltsas SD, Spiliopoulou CA, Mykoniatis MG, Theocharis SE. Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats. Liver 1999; 19: 519-525
4. Liatsos GD, Mykoniatis MG, Margeli A, Liakos AA, Theocharis SE. Effect of acute ethanol exposure on hepatic stimulator substance (HSS) levels during liver regeneration: protective function of HSS. Dig Dis Sci 2003; 48: 1929-1938
5. Zhou Z, Tan R, Su S, Zhou C. Effects of human HSS on hepatocyte and hepatoma cell proliferation and D-GAL induced acute liver failure. Chin Med Sci 11992; 7: 197-200
6. Yao ZQ, Yang WS, Zhang WB, Chen Y, Zhou YX. Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chin Med J (Engl) 1992; 105: 676-683
7. Francavilla A, Azzarone A, Carrieri G, Cillo U, Van Thiel D, Subbottin V, Starzl TE. Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology 1993; 17: 429-433
8. Mei MH, An W, Zhang BH, Shao Q, Gong DZ. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 1993; 17: 638-644
9. Theocharis SE, Margeli AP, Agapitos EV, Mykoniatis MG, Kittas CN, Davaris PS. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats. Scand J Gastroenterol 1998; 33: 656-663
10. Zhang BH, Gong DZ, Mei MH. Protection of regenerating liver after partial hepatectomy from carbon tetrachloride hepatotoxicity in rats: role of hepatic stimulator substance. J Gastroenterol Hepatol 1999; 14: 1010-1017
11. Margeli AP, Papadimitriou L, Ninos S, Manolis E, Mykoniatis MG, Theocharis SE. Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy. Liver Int 2003; 23: 171-178
12. Zhang M, Song G, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat. Gastroenterology 1996; 110: 1150-1155
13. Theocharis SE, Margeli AP, Spiliopoulou C, Skaltsas S, Kittas C, Koutselinis A. Hepatic stimulator substance administration enhances regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectornized rats. Dig Dis Sci 1996; 41: 1475-1480
14. Jiang B, Sawa M, Yamamoto T, Kasai S. Enhancement of proliferation of intrasplenically transplanted hepatocytes in cirrhotic rats by hepatic stimulatory substance. Transplantation 1997; 63: 131-135
15. Francavilla A, DiLeo A, Polimeno L, Gavaler J, Pellicci R, Todo S, Kam I, Prelich J, Makowka L, Starzl TE. The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1986; 6: 1346-1351
16. Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J, Van Thiel DH, Starzl TE. Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res 1987; 47: 5600-5605
17. Francavilla A, Barone M, Van Thiel DH, Mazzaferro V, Prelich JG, Starzl TE. Further steps of hepatic stimulatory substance purification. Dig Dis Sci 1991; 36: 674-680
18. Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo U, Porter K, Starzl TE. Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology 1992; 16: 1267-1270
19. Francavilla A, Polimeno L, Barone M, Azzarone A, Starzl TE. Hepatic regeneration and growth factors. J Surg Oncol Suppl 1993; 3: 1-7
20. Francavilla A, Hagiya M, Porter KA, Polimeno L, Ihara I, Starzl TE. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology 1994; 20: 747-757
21. Webber EM, Godowski PJ, Fausto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994; 19: 489-497
22. Terblanche J, Porter KA, Starzl TE, Moore J, Patzelt L, Hayashida N. Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet 1980; 151: 538-544
23. Starzl TE, Porter KA, Putnam CW. Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 1975; 2: 1241-1242
24. Starzl TE, Jones AF, Terblanche J, Usui S, Porter KA, Mazzoni G. Growth-stimulating factor in regenerating canine liver. Lancet 1979; 1: 127-130
25. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, Shimonishi M, Porter KA, Starzl TE. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci USA 1994; 91: 8142-8146
26. Giorda R, Hagiya M, Seki T, Shimonishi M, Sakai H, Michaelson J, Francavilla A, Starzl TE, Trucco M. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996; 2: 97-108
27. Lisowsky T, Weinstat-Saslow DL, Barton N, Reeders ST, Schneider MC. A new human gene located in the PKD1 region of chromosome 16 is a functional homologue to ERV1 of yeast. Genomics 1995; 29: 690-697
28. Lisowsky T. Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast. Mol Gen Genet 1992; 232: 58-64
29. Coppock DL, Cina-Poppe D, Gilleran S. The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. Genomics 1998; 54: 460-468
30. Stein G, Lisowsky T. Functional comparison of the yeast scERV1 and scERV2 genes. Yeast 1998; 14: 171-180
31. Yanez RJ, Rodriguez JM, Nogal ML, Yuste L, Enriquez C, Rodriguez JF, Vinuela E. Analysis of the complete nucleotide sequence of African swine fever virus. Virology 1995; 208: 249-278
32. Lisowsky T. ERV1 is involved in the cell-division cycle and the maintenance of mitochondrial genomes in Saccharomyces cerevisiae. Curr Genet 1994; 26: 15-20
33. Lisowsky T. Removal of an intron with unique 3′ branch site creates an amino-terminal protein sequence directing the scERV1 gene product to mitochondria. Yeast 1996; 12: 1501-1510
34. Becher D, Kricke J, Stein G, Lisowsky T. A mutant for the yeast scERV1 gene displays a new defect in mitochondrial morphology and distribution. Yeast 1999; 15: 1171-1781
35. Lee J, Hofhaus G, Lisowsky T. Erv1p from Saccharomyces cerevisiae is a FAD-linked sulfhydryl oxidase. FEBS Lett 2000; 477: 62-66
36. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, Shimonishi M, Porter KA, Starzl TE. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci USA 1995;92: 3076
37. Dong J, Cheng J, Wang Q, Shi S, Wang G, Si C. Cloning and analysis of the genomic DNA sequence of augmenter of liver regeneration from rat. Chin Med Sci 12002; 17: 63-67
38. Dong J, Cheng J, Liu Y, Wang Q, Wang G, Shi S, Si C. Cloning and sequence analysis of a pseudogene of liver regeneration augmenter in rats. Zhonghua Ganzangbing Zazhi 2001; 9: 105-107
39. Wu CK, Dailey TA, Dailey HA, Wang BC, Rose JP. The crystal structure of augmenter of liver regeneration: A mammalian FAD-dependent sulfhydryl oxidase. Protein Sci 2003; 12: 1109-1118
40. Yang XM, Xie L, Qiu ZH, Wu C, He FC. Cloning and characterizing of a new type human liver regeneration augmenter. Sci China 1997; 6: 642-647
41. Cheng J, Zhong YW, Liu Y, Dong J, Yang JZ, Chen JM. Cloning and sequence analysis of human genomic DNA of augmenter of liver regeneration. World J Gastroenterol 2000; 6: 275-277
42. Cheng J, Zhong Y. Cloning and sequence analysis of human genomic DNA of augmenter of liver regeneration hepatitis. Zhonghua Ganzangbing Zazhi 2000; 8: 12-14
43. Lu J, Xu WX, Zhan YQ, Cui XL, Cai WM, He FC, Yang XM. Identification and characterization of a novel isoform of hepatopoietin. World J Gastroenterol 2002; 8: 353-356
44. Li Y, Wei K, Lu C, Li Y, Li M, Xing G, Wei H, Wang Q, Chen J, Wu C, Chen H, Yang S, He F. Identification of hepatopoietin dimerization, its interacting regions and alternative splicing of its transcription. Eur J Biochem 2002; 269: 3888-3893
45. Lange H, Lisowsky T, Gerber J, Muhlenhoff U, Kispal G, Lill R. An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep 2001; 2: 715-720
46. Cheng J, Wang L, Li K, Lu YY, Wang G, Liu Y, Zhong YW, Duan HJ, Hong Y, Li L, Zhang LX, Chen JM. Screening of augmenter of liver regeneration-binding proteins by yeast-two hybrid technique. Hepatobiliary Pancreat Dis Int 2003; 2: 81-84
47. Zhao Y, Tang F, Cheng J, Li L, Xing G, Zhu Y, Zhang L, Wei H, He F. An initiator and its flanking elements function as a core promoter driving transcription of the Hepatopoietin gene. FEBS Lett 2003; 540: 58-64
48. Polimeno L, Lisowsky T, Francavilla A. From yeast to man-from mitochondria to liver regeneration: a new essential gene family. Ital J Gastroenterol Hepatol 1999; 31: 494-500
49. Hofhaus G, Stein G, Polimeno L, Francavilla A, Lisowsky T. Highly divergent amino termini of the homologous human ALR and yeast scERV1 gene products define species specific differences in cellular localization. Eur J Cell Biol 1999; 78: 349-356
50. Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 2001; 33: 173-180
51. Hoober KL, Joneja B, White HB 3rd, Thorpe C. A sulfhydryl oxidase from chicken egg white. J Biol Chem 1996; 271: 30510-30516
52. Hoober KL, Glynn NM, Burnside J, Coppock DL, Thorpe C. Homology between egg white sulfhydryl oxidase and quiescin Q6 defines a new class of flavin-linked suffhydryl oxidases. J Biol Chem 1999; 274: 31759-31762
53. Hoober KL, Thorpe C. Egg white sulfhydryl oxidase: kinetic mechanism of the catalysis of disulfide bond formation. Biochemistry 1999; 38: 3211-3217
54. Kobayashi T, Ito K. Respiratory chain strongly oxidizes the CXXC motif of DsbB in the Escherichia coli disulfide bond formation pathway. EMBO J 1999; 18: 1192-1198
55. Bader M, Muse W, Ballou DP, Gassner C, Bardwell JC. Oxidative protein folding is driven by the electron transport system. Cell 1999; 98: 217-227
56. Farrell SR, Thorpe C. Augmenter of liver regeneration: a flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity. Biochemistry 2005; 44: 1532-1541
57. Wang G, Yang X, Zhang Y, Wang Q, Chen H, Wei H, Xing G, Xie L, Hu Z, Zhang C, Fang D, Wu C, He F. Identification and characterization of receptor for man-unalian hepatopoietin that is homologous to yeast ERV1. J Biol Chem 1999; 274: 11469-11472
58. Yang XM, Hu ZY, Xie L, Wu ZZ, Wu CT, He FC. In vitro stimulation of HTC hepatoma cell growth by recombinant human augmenter of liver regeneration (ALR). Shengli Xuebao 1997; 49: 557-561
59. Yang XM, Xie L, He H, Wei HD, Wu ZZ, He FC. Expression and Activity of Recombinant Human Augmenter of Liver Regeneration. Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 1997; 29: 414-418
60. Li Y, Li M, Xing G, Hu Z, Wang Q, Dong C, Wei H, Fan G, Chen J, Yang X, Zhao S, Chen H, Guan K, Wu C, Zhang C, He F. Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin. J Biol Chem 2000; 275: 37443-37447
61. Lu C, Li Y, Zhao Y, Xing G, Tang F, Wang Q, Sun Y, Wei H, Yang X, Wu C, Chen J, Guan KL, Zhang C, Chen H, He F. Intracrine hepatopoietin potentiates AP-1 activity through JAR1 independent of MAPK pathway. FASEB J 2002; 16: 90-92
62. Wang Y, Lu C, Wei H, Wang N, Chen X, Zhang L, Zhai Y, Zhu Y, Lu Y, He F. Hepatopoietin interacts directly with COP9 signalosome and regulates AP-1 activity. FEBS Lett 2004; 572: 85-91
63. Chen X, Li Y, Wei K, Li L, Liu W, Zhu Y, Qiu Z, He F. The potentiation role of hepatopoietin on activator protein-1 is dependent on its sulfhydryl oxidase activity. J Biol Chem 2003; 278: 49022-49030
64. Li Y, Lu C, Xing G, Zhu Y, He F. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Exp Cell Res 2004; 300: 379-387
65. Gandhi CR, Kuddus R, Subbotin VM, Prelich J, Murase N, Rao AS, Nalesnik MA, Watkins SC, DeLeo A, Trucco M, Starzl TE. A fresh look at augmenter of liver regeneration in rats. Hepatology 1999; 29: 1435-1445
66. Polimeno L, Capuano F, Marangi LC, Margiotta M, Lisowsky T, Ierardi E, Francavilla R, Francavilla A. The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver n-dtochondria. Dig Liver Dis 2000; 32: 510-517
67. Francavilla A, Vujanovic NL, Polimeno L, Azzarone A, Iacobellis A, Deleo A, Hagiya M, Whiteside TL, Starzl TE. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997; 25: 411-415
68. Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. I Gastroenterol 2000; 35: 112-119
69. Polimeno L, Margiotta M, Marangi L, Lisowsky T, Azzarone A, lerardi E, Frassanito MA, Francavilla R, Francavilla A. Molecular mechanisms of augmenter of liver regeneration as inummoregulator: its effect on interferon-gamma expression in rat liver. Dig Liver Dis 2000; 32: 217-225
70. Cheng J, Wang L, Li K, Lu YY, Liu Y, Duan HJ, Hong Y, Wang G, Li L, Zhang LX. Cloning and expression of the gene of augmeUse of liver regeneration in yeast cells. Hepatobiliary Pancreat Dis Int 2002; 1: 87-91
71. Liu Q, Yu HF, Sun H, Ma HF. Expression of human augmenter of liver regeneration in pichia, pastoris yeast and its bioactivity in vitro. World J Gastroenterol 2004; 10: 3188-3190
72. Li Q, Liu DW, Zhang LM, Zhu B, He YT, Xiac, YH. Effects of augmentation of liver regeneration recombinant plasmid on rat hepatic fibrosis. World J Gastroenterol 2005; 11: 2438-2443
73. Klissenbauer M, Winters S, Heinlein UA, Lisowsky T. Accumulation of the mitochondrial form of the sulphydryl oxidase Erv1p/Alrp during the early stages of spermatogenesis. J Exp Biol 2002; 205: 1979-1986